Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cerebrovascular Disorders
  Free Subscription

Articles published in
Circulation
    April 2024
  1. ARMOUNDAS AA, Narayan SM, Arnett DK, Spector-Bagdady K, et al
    Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1028-e1050.
    >> Share

    March 2024
  2. PATEL SM, Ruff CT
    Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
    Circulation. 2024;149:989-992.
    >> Share

  3. KHAN F, Coutts SB, Hill MD
    Letter by Khan et al Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020".
    Circulation. 2024;149:797-798.
    >> Share

  4. VINDING NE, Fosbol EL
    Response by Vinding and Fosbol to Letter Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020".
    Circulation. 2024;149:799.
    >> Share

    February 2024
  5. ELKIND MSV, Arnett DK, Benjamin IJ, Eckel RH, et al
    The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Feb 12. doi: 10.1161/CIR.0000000000001213.
    >> Share

  6. GREEN JB, Everett BM, Ghosh A, Younes N, et al
    Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604.
    >> Share

  7. GALEA R, Meneveau N, De Marco F, Aminian A, et al
    One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2024;149:484-486.
    >> Share

    January 2024
  8. MARTIN SS, Aday AW, Almarzooq ZI, Anderson CAM, et al
    2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
    Circulation. 2024 Jan 24. doi: 10.1161/CIR.0000000000001209.
    >> Share

  9. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    >> Share

    December 2023
  10. PRAPIADOU S, Zivkovic L, Thorand B, George MJ, et al
    Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.064974.
    >> Share

  11. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    >> Share

    November 2023
  12. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    >> Share

  13. MCINTYRE WF, Benz AP, Becher N, Healey JS, et al
    Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512.
    >> Share

    October 2023
  14. RODES-CABAU J, Ribeiro H, Mohammadi S, Serra V, et al
    Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.067326.
    >> Share

  15. GLENN AJ, Guasch-Ferre M, Malik VS, Kendall CWC, et al
    Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies.
    Circulation. 2023 Oct 25. doi: 10.1161/CIRCULATIONAHA.123.065551.
    >> Share

  16. HONG SJ, Lee SJ, Suh Y, Yun KH, et al
    Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial.
    Circulation. 2023 Oct 25. doi: 10.1161/CIRCULATIONAHA.123.066943.
    >> Share

  17. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    >> Share

  18. BABER U, Jang Y, Oliva A, Cao D, et al
    Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials.
    Circulation. 2023 Oct 23. doi: 10.1161/CIRCULATIONAHA.123.067283.
    >> Share

  19. RAYCHEV R, Sun JL, Schwamm L, Smith EE, et al
    Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines-Stroke Registry.
    Circulation. 2023 Oct 19. doi: 10.1161/CIRCULATIONAHA.123.066114.
    >> Share

  20. HOWARD G, Cushman M, Blair J, Wilson NR, et al
    Comparative Discrimination of Life's Simple 7 and Life's Essential 8 to Stratify Cardiovascular Risk: Is the Added Complexity Worth It?
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065472.
    >> Share

    September 2023
  21. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
    Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
    Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
    >> Share

    August 2023
  22. JOOSTEN LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485.
    >> Share

  23. VINDING NE, Butt JH, Lauridsen MD, Kristensen SL, et al
    Long-term Incidence of Ischemic Stroke Following Transient Ischemic Attack: A Nationwide Study During 2014-2020.
    Circulation. 2023 Aug 25. doi: 10.1161/CIRCULATIONAHA.123.065446.
    >> Share

  24. ZIMMERMANN FM, Ding VY, Pijls NHJ, Piroth Z, et al
    Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
    Circulation. 2023 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.065770.
    >> Share

  25. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Response by Zeitler et al to Letter Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:510-511.
    >> Share

  26. JIAO T, Ruzieh M
    Letter by Jiao and Ruzieh Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:508-509.
    >> Share

    July 2023

  27. Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
    Circulation. 2023;148:e4.
    >> Share

  28. VAN DE WERF F, Ristic AD, Averkov OV, AriasMendoza A, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial.
    Circulation. 2023 Jul 13. doi: 10.1161/CIRCULATIONAHA.123.064521.
    >> Share

    May 2023
  29. MAN S, Solomon N, Mac Grory B, Alhanti B, et al
    Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064053.
    >> Share

  30. SATTAR N, McMurray J, Boren J, Rawshani A, et al
    Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.063374.
    >> Share

    April 2023

  31. Correction to: Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study.
    Circulation. 2023;147:e716.
    >> Share

  32. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Effects of Systematic Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: a Secondary Analysis of the Randomized LOOP Study.
    Circulation. 2023 Apr 15. doi: 10.1161/CIRCULATIONAHA.123.064361.
    >> Share

  33. HARRINGTON J, Carnicelli AP, Hua K, Wallentin L, et al
    Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Circulation. 2023 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.062752.
    >> Share

  34. ALBERT MA
    Economic Adversity and Health Care: Synopsis of American Heart Association Presidential Address.
    Circulation. 2023;147:1115-1117.
    >> Share

    March 2023
  35. GRECO A, Laudani C, Spagnolo M, Agnello F, et al
    Pharmacology and Clinical Development of Factor XI Inhibitors.
    Circulation. 2023;147:897-913.
    >> Share

  36. ASIF KS, Otite FO, Desai SM, Herial N, et al
    Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study.
    Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063366.
    >> Share

  37. CAMPBELL DJT, Mitchell C, Hemmelgarn BR, Tonelli M, et al
    Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064188.
    >> Share

    February 2023

  38. Correction to: Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation.
    Circulation. 2023;147:e623.
    >> Share


  39. Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
    Circulation. 2023;147:e622.
    >> Share

  40. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
    Circulation. 2023;147:586-596.
    >> Share

  41. GABA P, O'Donoghue ML, Park JG, Wiviott SD, et al
    Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
    Circulation. 2023 Feb 13. doi: 10.1161/CIRCULATIONAHA.122.063399.
    >> Share

  42. LAWAL OD, Aronow HD, Shobayo F, Hume AL, et al
    Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
    Circulation. 2023 Feb 10. doi: 10.1161/CIRCULATIONAHA.122.060687.
    >> Share

    January 2023
  43. TSAO CW, Aday AW, Almarzooq ZI, Anderson CAM, et al
    Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
    Circulation. 2023 Jan 25. doi: 10.1161/CIR.0000000000001123.
    >> Share

  44. AVITZUR O
    Ralph L. Sacco, 65, Dies: Stroke Expert With a Talent for Architectural Design.
    Circulation. 2023 Jan 17. doi: 10.1161/CIR.0000000000001127.
    >> Share

  45. NTSEKHE M, Baker JV
    Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
    Circulation. 2023;147:83-100.
    >> Share

    December 2022
  46. WEITZ JI, Eikelboom JW
    What Is the Future of Factor XI Inhibitors?
    Circulation. 2022;146:1899-1902.
    >> Share

  47. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    >> Share

  48. ALAHMAD B, Khraishah H, Roye D, Vicedo-Cabrera AM, et al
    Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries.
    Circulation. 2022 Dec 12. doi: 10.1161/CIRCULATIONAHA.122.061832.
    >> Share

  49. BENZ AP, Eikelboom JW
    Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned.
    Circulation. 2022;146:1746-1748.
    >> Share

    November 2022

  50. Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022;146:e279.
    >> Share

  51. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
    Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Circulation. 2022;146:1461-1474.
    >> Share

  52. WU H, Xu L, Zhao X, Zhang H, et al
    Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-eluting Stent Implantation (OPTION): a Randomized, Open-label, Endpoint-blinded, Non-inferiority Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062762.
    >> Share

  53. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
    >> Share

  54. POKORNEY SD, Chertow GM, Al-Khalidi HR, Gallup D, et al
    Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.121.054990.
    >> Share

    October 2022
  55. GAZIANO L, Sun L, Arnold M, Bell S, et al
    Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.060700.
    >> Share

    September 2022

  56. Correction to: Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022;146:e141.
    >> Share

  57. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
    >> Share

    August 2022
  58. O'DONOGHUE ML, Giugliano RP, Wiviott SD, Atar D, et al
    Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061620.
    >> Share

  59. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
    State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Aug 18:101161CIR0000000000001089.
    >> Share

  60. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
    Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
    >> Share

    July 2022
  61. KUEHN BM
    Nurse Navigators Cut Stroke Readmissions by Half.
    Circulation. 2022;146:140-141.
    >> Share

  62. HANKEY GJ
    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.
    >> Share

    June 2022
  63. VAN BELLE E, Debry N, Vincent F, Kuchcinski G, et al
    Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort.
    Circulation. 2022 Jun 20:101161CIRCULATIONAHA121057145.
    >> Share

  64. HUGUENARD AL, Johnson GW, Osbun JW, Dacey RG, et al
    Frequency of Screening-Detected Intracranial Aneurysms in Patients With Loeys-Dietz Syndrome.
    Circulation. 2022 Jun 17:101161CIRCULATIONAHA122058948.
    >> Share

  65. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    >> Share

  66. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    >> Share

    April 2022
  67. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    >> Share

  68. LAKKIREDDY D, Thaler D, Windecker S
    Response by Lakireddy et al to Letters Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e850-e851.
    >> Share

  69. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    >> Share

  70. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    >> Share

  71. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    >> Share

    March 2022
  72. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    >> Share

  73. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    >> Share

  74. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    >> Share

  75. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    >> Share

    January 2022
  76. TSAO CW, Aday AW, Almarzooq ZI, Alonso A, et al
    Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022 Jan 26:CIR0000000000001052. doi: 10.1161/CIR.0000000000001052.
    >> Share

    December 2021
  77. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    >> Share

  78. ZHENG F, von Spreckelsen N, Hu W
    Letter by Zheng et al Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e491-e492.
    >> Share

  79. TRIFAN G, Gorelick PB, Testai FD
    Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e493-e494.
    >> Share

    November 2021
  80. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    >> Share

  81. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    >> Share

    October 2021
  82. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    >> Share

    September 2021
  83. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    >> Share

  84. WITSCH J, Mir SA, Parikh NS, Murthy SB, et al
    Association Between Cervical Artery Dissection and Aortic Dissection.
    Circulation. 2021;144:840-842.
    >> Share

  85. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    >> Share

    July 2021
  86. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    >> Share

    May 2021
  87. KUWABARA M, Mori M, Komoto S
    Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease.
    Circulation. 2021;143:1929-1931.
    >> Share

    April 2021
  88. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
    Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e809-e810.
    >> Share

    February 2021
  89. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    >> Share

  90. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    >> Share

  91. HEMELSOET D, De Keyser J, Van Heuverswyn F, Willems R, et al
    Screening for Fabry Disease in Male Patients With Arrhythmia Requiring a Pacemaker or an Implantable Cardioverter-Defibrillator.
    Circulation. 2021;143:872-874.
    >> Share

    January 2021
  92. SAADOUN D, Vautier M, Cacoub P
    Medium- and Large-Vessel Vasculitis.
    Circulation. 2021;143:267-282.
    >> Share

    October 2020
  93. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    >> Share

  94. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    >> Share

  95. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016